Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

Sigachi factory blast: Investigation progressing, no arrests yet, state informs Telangana High Court post image
pharma-industry business earnings

Sigachi factory blast: Investigation progressing, no arrests yet, state informs Telangana High Court

by Newsdesk
Bugonia: A Riveting Ride Through Dystopian Realities post image
pharma-industry business earnings

Bugonia: A Riveting Ride Through Dystopian Realities

by Newsdesk
Denmark's Growth Forecasts Dim Amid Novo Challenges and Tariffs post image
pharma-industry business earnings

Denmark's Growth Forecasts Dim Amid Novo Challenges and Tariffs

Featured post
by Newsdesk
Ameriprise Financial Inc. Purchases 6,692 Shares of West Pharmaceutical Services, Inc. $WST post image
pharma-industry business earnings

Ameriprise Financial Inc. Purchases 6,692 Shares of West Pharmaceutical Services, Inc. $WST

by Newsdesk
Amanta Healthcare IPO: Latest GMP Signals Over 17% Listing Gain Ahead Of Sept. 1 Launch, Check Key Details post image
pharma-industry business earnings

Amanta Healthcare IPO: Latest GMP Signals Over 17% Listing Gain Ahead Of Sept. 1 Launch, Check Key Details

by Newsdesk
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025 post image
digital-health ai health-tech

Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025

by Newsdesk
Mounjaro to be discounted in UK pharmacies as US drug giant U-turns on price hikes post image
pharma-industry business earnings

Mounjaro to be discounted in UK pharmacies as US drug giant U-turns on price hikes

by Newsdesk
Denmark Slashes 2025 Economic Growth Forecast Amid Novo Nordisk Woes post image
pharma-industry business earnings

Denmark Slashes 2025 Economic Growth Forecast Amid Novo Nordisk Woes

by Newsdesk
Clinical trial leads to FDA approval of drug for rare, deadly blood cancer post image
regulatory fda clinical-trials

Clinical trial leads to FDA approval of drug for rare, deadly blood cancer

by Newsdesk
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program post image
regulatory fda clinical-trials

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

by Newsdesk
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers post image
regulatory fda clinical-trials

D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers

by Newsdesk
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer post image
regulatory fda clinical-trials

Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer

by Newsdesk